RCM Technologies RCMT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Business | ||||||
| Corporate | $0— | $0— | $0— | $0— | $0— | |
| Engineering | $114.48M+8.9% | $120.49M+24.9% | $116.36M+25.3% | $109.11M+19.7% | $105.1M+17.2% | |
| Life Sciences Data Solutions | $34.56M-9.1% | $34.81M-11.3% | $36.36M-9.5% | $37.14M-9.7% | $38.04M-9.4% | |
| Specialty Health Care | $168.93M+14.3% | $164.1M+15.0% | $157.12M+13.6% | $153.67M+12.4% | $147.78M+9.2% | |
| Gross Profit by Business | ||||||
| Corporate | $0— | $0— | $0— | $0— | $0— | |
| Engineering | $26.5M+14.1% | $27.38M+21.5% | $24.77M+5.4% | $23.75M+2.4% | $23.23M+5.3% | |
| Life Sciences Data Solutions | $12.85M-11.4% | $13.16M-10.5% | $14.46M-2.9% | $14.62M-4.3% | $14.5M-8.9% | |
| Specialty Health Care | $48.64M+11.4% | $47.4M+11.4% | $46.01M+12.2% | $45.3M+12.8% | $43.66M+11.0% | |
| Operating Income by Business | ||||||
| Corporate | -$19.17M-11.3% | -$18.65M-47.6% | -$18.93M-148% | -$17.99M-348% | -$17.23M— | |
| Engineering | $14.13M+34.1% | $14.64M+65.5% | $11.77M+35.7% | $10.88M+55.9% | $10.54M+144% | |
| Life Sciences Data Solutions | $6.24M-32.0% | $6.32M-23.2% | $9.69M+52.5% | $9.56M+57.3% | $9.18M+49.5% | |
| Specialty Health Care | $23.25M+12.9% | $22.79M+27.4% | $20.87M+29.9% | $21.41M+50.4% | $20.59M+62.9% | |
| Total Assets by Business | ||||||
| Corporate | $47.09M-3.9% | $47.71M+9.3% | $48.88M+19.8% | $51.33M+46.1% | $48.99M+64.3% | |
| Engineering | $239.45M+20.1% | $222.64M+10.0% | $214.24M+8.9% | $210.25M+10.5% | $199.35M+7.4% | |
| Life Sciences Data Solutions | $60.87M-43.9% | $91.55M+10.7% | $99.83M+26.3% | $104.59M— | $108.49M— | |
| Specialty Health Care | $187.72M+34.0% | $158.88M-5.2% | $155.52M-7.5% | $148.03M-7.5% | $140.06M-12.3% | |
| Cost of Goods Sold by Business | ||||||
| Corporate | $0— | $0— | $0— | $0— | $0— | |
| Engineering | $87.98M+7.5% | $93.1M+26.0% | $91.59M+32.0% | $85.36M+25.6% | $81.87M+21.1% | |
| Life Sciences Data Solutions | $21.72M-7.7% | $21.66M-11.8% | $21.9M-13.5% | $22.52M-12.9% | $23.54M-9.8% | |
| Specialty Health Care | $120.29M+15.5% | $116.7M+16.5% | $111.11M+14.1% | $108.37M+12.3% | $104.12M+8.5% | |
| Selling General And Administrative Expense by Business | ||||||
| Corporate | $18.51M+11.8% | $18.04M+49.5% | $18.34M+153% | $17.52M+375% | $16.55M— | |
| Engineering | $11.55M-4.1% | $11.98M-8.4% | $12.28M-13.7% | $12.21M-22.2% | $12.04M-30.1% | |
| Life Sciences Data Solutions | $6.47M+2.8% | $6.7M-9.5% | $5.82M-29.0% | $6.06M-31.6% | $6.29M-33.4% | |
| Specialty Health Care | $24.97M+10.1% | $24.22M-0.1% | $24.76M+0.9% | $23.5M-8.0% | $22.68M-13.8% | |
| Depreciation Nonproduction by Business | ||||||
| Corporate | $666K+86.6% | $606K+148% | $528K+250% | $405K+487% | $357K— | |
| Engineering | $823K+27.0% | $771K+24.0% | $716K+22.0% | $667K+23.3% | $648K+25.3% | |
| Life Sciences Data Solutions | $144K-7.1% | $148K-3.3% | $153K+3.2% | $160K+11.5% | $155K+5.6% | |
| Specialty Health Care | $415K+4.8% | $393K-1.8% | $374K-6.0% | $393K+2.3% | $396K+2.6% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Corporate | $592K-60.0% | $841K-46.0% | $1.64M-37.5% | $1.42M-44.7% | $1.48M-35.2% | |
| Engineering | $455K-18.5% | $480K-30.5% | $451K-36.1% | $689K+40.6% | $558K-12.1% | |
| Life Sciences Data Solutions | $1K-98.5% | $55K+96.4% | $59K+16.3% | $59K-27.6% | $68K-36.0% | |
| Specialty Health Care | $217K-3.1% | $219K-26.0% | $236K-11.6% | $239K-8.4% | $224K-2.6% | |
| Goodwill by Business | ||||||
| Engineering | $47.67M0.0% | $47.67M0.0% | $47.67M0.0% | $47.67M0.0% | $47.67M0.0% | |
| Life Sciences Data Solutions | $31.32M— | $31.32M— | $31.32M— | —— | —— | |
| Specialty Health Care | $9.59M0.0% | $9.59M0.0% | $9.59M0.0% | $9.59M0.0% | $9.59M0.0% | |
| Revenue (Gross) by Product | ||||||
| Engineering Services | $114.48M+8.9% | $120.49M+24.9% | $116.36M+25.3% | $109.11M+19.7% | $105.1M+17.2% | |
| Health Care | $168.93M+14.3% | $164.1M+15.0% | $157.12M+13.6% | $153.67M+12.4% | $147.78M+9.2% | |
| Technology Service | $34.56M-9.1% | $34.82M-11.3% | $36.37M-11.8% | $37.14M-12.2% | $38.04M-11.7% | |
| Revenue (Gross) by Geography | ||||||
| CA | $6.92M-9.4% | $7.54M+4.7% | $7.82M+22.2% | $7.97M+29.5% | $7.64M+20.0% | |
| Europe | $15.44M+95.4% | $15.32M+107% | $11.46M+84.4% | $7.4M+29.4% | $7.9M+70.9% | |
| PR | $6.52M-1.6% | $6.36M-9.3% | $6.1M-17.1% | $6.15M-17.3% | $6.62M-4.8% | |
| US | $289.09M+7.6% | $290.19M+13.0% | $284.46M+12.6% | $278.4M+11.0% | $268.75M+7.5% | |
| Total Assets by Geography | ||||||
| CA | $7.01M+14.3% | $6.17M-2.9% | $5.76M-15.4% | $5.91M-11.9% | $6.13M-12.2% | |
| Europe | $23.04M+35.1% | $18.89M+16.5% | $15.7M-8.5% | $18.12M+22.3% | $17.05M+15.5% | |
| PH | $218.03M— | $413.61M— | $413.35M— | —— | —— | |
| PR | $10.93M-9.1% | $11.18M-4.8% | $11.83M-0.9% | $12.48M-3.7% | $12.02M-6.6% | |
| US | $492.9M+6.8% | $483.54M+4.7% | $484.42M+7.9% | $477.22M+12.0% | $461.44M+11.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does RCM Technologies break its business down?
- RCM Technologies (RCMT) reports revenue (gross) by business across 4 parts — Corporate, Engineering, Life Sciences Data Solutions and Specialty Health Care. Each is extracted from the segment footnotes and tracked over time.
- Where does RCM Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in RCM Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
